These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 18207066)

  • 1. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome and cutaneous vasoocclusive disorders.
    Grattan CE; Burton JL
    Semin Dermatol; 1991 Sep; 10(3):152-9. PubMed ID: 1931563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
    Kriseman YL; Nash JW; Hsu S
    J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
    Francès C; Niang S; Laffitte E; Pelletier Fl; Costedoat N; Piette JC
    Arthritis Rheum; 2005 Jun; 52(6):1785-93. PubMed ID: 15934071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic encephalopathy in primary antiphospholipid syndrome].
    Thomas P; Lebrun C; Mahagne MH; Desnuelles C; Chatel M
    Rev Neurol (Paris); 1993; 149(5):336-9. PubMed ID: 8272729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dermatologic manifestations of the antiphospholipid syndrome].
    Francès C; Barete S; Soria A
    Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
    Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
    Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?
    Acland KM; Darvay A; Wakelin SH; Russell-Jones R
    Br J Dermatol; 1999 Jan; 140(1):131-5. PubMed ID: 10215783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous expressions of antiphospholipid syndromes.
    Eng AM
    Semin Thromb Hemost; 1994; 20(1):71-8. PubMed ID: 8059236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations associated with antiphospholipid antibodies.
    Diógenes MJ; Diógenes PC; de Morais Carneiro RM; Neto CC; Duarte FB; Holanda RR
    Int J Dermatol; 2004 Sep; 43(9):632-7. PubMed ID: 15357740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
    Kontic M; Stojanovich L; Mijailović-Ivković M; Velinović M; Srnka J; Zdravkovic M
    Clin Exp Rheumatol; 2018; 36(1):56-61. PubMed ID: 28770705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome.
    Duval A; Darnige L; Glowacki F; Copin MC; Martin De Lassalle E; Delaporte E; Auxenfants E
    J Am Acad Dermatol; 2009 Dec; 61(6):1076-8. PubMed ID: 19646781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.